ABOUT US
With a rich heritage dating back hundreds of years, Cytiva brings a wealth of technical expertise and talent, a broad and deep portfolio, and exceptional service help researchers and biopharma advance therapeutics at every stage from discovery to delivery.
We supply the tools and support our customers need to work better, faster, and safer, leading to the delivery of transformative medicines to patients. Our combined portfolio includes well-recognized names such as Allegro™, Supor™, iCELLis™, and Kleenpak™, in addition to ÄKTA™, Amersham™, Biacore™, FlexFactory™, HyClone™, MabSelect™, Sefia™, Whatman™, and Xcellerex™. Visit cytiva.com to learn more.
VIDEOS
WEBINARS
BROCHURES AND DATASHEETS
- Advanced Automation System For Flexible Aseptic Filling
- Bioreactors Designed For Cell Growth And Expansion
- Antibody Production: Scale-Up Menu
- Allegro MVP Single-Use System
- An IoT Solution For A Reliable, Real-Time Informed Diagnosis
- A Flexible Service Model With Rapid Response And Access To Knowledge
- Online Service Solutions For Optimal Performance Of Your Instruments
- Single‑Use Filtration System For Pilot‑ And Small‑Scale Manufacturing
- A Ready-To-Use, Single-Use Liquid Chromatography System
- Mechanistic Chromatography Modeling To Accelerate Process Development
APPLICATION NOTES
- Balancing Protein A Resin Cost, Performance, And Productivity
- Optimizing TFF And SPTFF For High-Concentration mAb Formulations
- Selecting A Platform Filter For High Concentration mAbs
- Production Of A Highly Concentrated Monoclonal Antibody
- Extractables In Single-Use Systems Used In ADC Manufacturing
- Adapting Single-Use Chromatography To Manufacturing Scale
- Developing A Large-Scale Tangential Flow Filtration Process
- Bulk Filling Of Drug Substance | Accurate Aliquoting
- Sterilizing Grade Filter Performance With Biologic Drugs
- Developing A HIC Polishing Step For The Removal Of mAb Aggregates
CONTACT INFORMATION
Cytiva
100 Results Way
Marlborough, MA 08855-1327
UNITED STATES
Phone: 800-526-3593
FEATURED ARTICLES
-
![GettyImages-2213157127-drug-formulation-discovery-pipette-liquid-vial]( "How One Biotech Company Is Accelerating The Drug Discovery Workflow")
See how biotech innovation is accelerating drug discovery through AI, miniaturized workflows, and collaborative technologies to reshape how therapies are developed and delivered.
-
![mRNA GettyImages-1428646288]( "Advanced Therapies Going Mainstream: Are We There Yet?")
Advanced therapies are nearing mainstream adoption, with cell, mRNA, and oligonucleotide treatments expanding into broader indications. Learn what’s driving this shift and what manufacturers must do.
-
![Scientists in lab-GettyImages-1441665026]( "Strategize For Success With Single-Use Biomanufacturing Systems")
Single-use technologies are reshaping biomanufacturing workflows. Discover the key stages of implementation and how strategic choices drive success across the entire production process.
-
![GettyImages-2036497889-lab-computer-research]( "Collaboration An Untapped Fuel For Driving Biopharma R&D")
Biopharma’s future depends on collaboration. Discover how cross-industry partnerships and shared resources can accelerate innovation, overcome talent gaps, and strengthen the global R&D ecosystem.
-
![Lipid Nanoparticles GettyImages-1437855772]( "How Lipid Nanoparticles Enable Next-Gen Delivery")
Cell therapy’s future depends on smarter gene delivery. Learn how lipid nanoparticles offer a scalable, cell-friendly alternative to electroporation and viral vectors for manufacturing efficiency.
-
![GettyImages-1600719545 lab]( "Why Biopharma Breakthroughs Aren't Moving The Market")
Biopharma is innovating fast but falling short commercially. Reveal key ecosystem gaps and five strategic actions to help strengthen resilience, accelerate performance, and futureproof organizations.
-
![GettyImages-1413607446-vial-syringe-liquid-scientist-glove]( "Your Biosimilar, Your Journey")
With many blockbuster drug patents set to expire by 2030, the market is ripe for biosimilar developers to stake their claim. To succeed, they must be strategic and compliant.
-
![GettyImages-2173433148 pfas]( "Take Action On PFAS To Protect Your Critical Processes")
PFAS restrictions are tightening, but a full ban could disrupt critical industries lacking alternatives, such as pharmaceutical manufacturing. Learn where PFAS use remains indispensable.
-
![GettyImages-2168071798-water-droplets-PFAS]( "What Are PFAS And How Do They Impact The Biotech Industry?")
Forever chemicals pose rising health risks and regulatory challenges. Learn how increasing restrictions on fluorinated compounds could reshape manufacturing, packaging, and sustainability strategies.
-
![Pharmaceutical-regulations-GettyImages-1423114910]( "Navigating The Regulatory Space To Biosimilar Approval")
The biosimilar patent cliff is reshaping pharma, creating unprecedented opportunities for biotech and CDMOs. Explore expert regulatory support that can help you navigate this shift with confidence.
